CLASS II ONGOING Device recall · Reported 18 Jan 2023 · FDA Enforcement Report

Source Administration Set (SAS) used recalled by Bayer Medical Care

Bayer Medical Care is recalling Source Administration Set (SAS) used with the Medrad Intego PET Infusion System, Sterile, distributed nationwide in the US. The recall was initiated on 30 Nov 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: (01)00616258021478(11)201209(17)231209(10)60272154 Batch number: 60272154 Expiration date: December 9, 2023
Quantity recalled2840 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0910-2023
FDA event ID
91273
Recalling firm
Bayer Medical Care, Indianola, PA
Classification
Class II
Status
Ongoing
Recall initiated
30 Nov 2022
FDA classified
6 Jan 2023
Reported
18 Jan 2023
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Packaging Defects

Timeline

30 Nov 2022Recall initiated by company
6 Jan 2023Classified by FDA+37 days
18 Jan 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Black specks may be present on the packaged needles

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Source Administration Set (SAS) used with the Medrad Intego PET Infusion System, Sterile Catalog number: INT CSS Affected material number: 86566621 Intended to deliver accurate doses of 18F Fluorodeoxyglucose (FDG) or 18F Sodium Fluoride (NaF) radiopharmaceuticals and commonly used flushing solutions to patients during molecular imaging (PET Positron Emission Tomography - nuclear medicine) diagnostic procedures.

Where it was distributed

Worldwide distribution - US Nationwide distribution in the states of AZ, IN, MN, NY, OH, TX, VA and the country of China.

Nationwide ArizonaIndianaMinnesotaNew YorkOhioTexasVirginia

Questions about this recall

Why was it recalled?

Black specks may be present on the packaged needles

Which lots are affected?

UDI: (01)00616258021478(11)201209(17)231209(10)60272154 Batch number: 60272154 Expiration date: December 9, 2023

Where was it sold?

Worldwide distribution - US Nationwide distribution in the states of AZ, IN, MN, NY, OH, TX, VA and the country of China.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Bayer Medical Care

All 9

Other Insulin Pumps & Glucose Monitors recalls

All 466